ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, P.
Right arrow Articles by Chien, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, P.
Right arrow Articles by Chien, K.

The Annals of Thoracic Surgery, Vol 35, 143-151, Copyright © 1983 by The Society of Thoracic Surgeons


ARTICLES

Surgical treatment of carcinoma of the esophagus and cardia among the Chinese

P Wang and K Chien

Clinical data on 1,450 patients with epidermoid carcinoma of the esophagus and 727 with adenocarcinoma of the cardia (seen from 1952 to 1980) are presented, with the results of surgical treatment in 387 epidermoid carcinomas and 164 adenocarcinomas. The rates of resectability, postoperative complications, and surgical mortality were 44.3%, 28.5%, and 5.1% in epidermoid carcinoma and 39.6%, 17.4%, and 5.9% in adenocarcinoma, respectively. Five-year survival after resection was 11.9% in epidermoid carcinoma and 6.7% in adenocarcinoma. The operative procedure is described. According to our experience, extensive resection of the esophagus followed by reconstruction of the alimentary tract with esophagoileocoloplasty or esophagogastrostomy retrosternally for the epidermoid carcinoma appears to be the treatment of choice. For adenocarcinoma of the cardia, resection of the tumor and esophagogastrostomy or esophagojejunostomy, can be done transthoracically if the esophageal involvement is not high. In any case, early diagnosis and early treatment are the only ways to improve the present results.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L.-S. Wang, K.-C. Chow, W.-Y. Li, C.-C. Liu, Y.-C. Wu, and M.-H. Huang
Clinical Significance of Serum Soluble Interleukin 2 Receptor-{{alpha}} in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., April 1, 2000; 6(4): 1445 - 1451.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C.-P. Hsu, C.-C. Wu, C.-Y. Chen, N.-Y. Hsu, Jiun-Yi-Hsia, and P.-Y. Wang
CLINICAL EXPERIENCE IN RADICAL LYMPHADENECTOMY FOR ADENOCARCINOMA OF THE GASTRIC CARDIA
J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 544 - 551.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Chen, Z. Yang, and Y. Li
Carcinomas of the esophagus and the cardia in young patients
J. Thorac. Cardiovasc. Surg., September 1, 1994; 108(3): 512 - 516.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1983 by The Society of Thoracic Surgeons.